These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7190314)

  • 1. Amitriptyline-induced suppression of growth hormone in acromegaly.
    Glass AR; Schaaf M; Dimond RC
    Psychoneuroendocrinology; 1980 Jan; 5(1):81-6. PubMed ID: 7190314
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relationship between suppression of growth hormone by CB-154 and prolactin secretion in acromegaly--indication for a long term care].
    Hara I; Kataoka K; Tomita A; Kuwayama A; Kageyama N
    Horumon To Rinsho; 1977 Dec; 25(12):1316-20. PubMed ID: 413675
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of blood somatotropin and phosphorus levels after administration of 2-bromo-alpha-ergocryptine].
    Romiti A; Martelletti P; Giacovazzo M
    Boll Soc Ital Biol Sper; 1978 Nov; 54(22):2257-9. PubMed ID: 754723
    [No Abstract]   [Full Text] [Related]  

  • 4. Bromocriptine in acromegaly.
    Thorner MO; Besser GM; Wass JA; Liuzzi A; Hall R; Muller EE; Chiodini PG
    N Engl J Med; 1981 Oct; 305(18):1092. PubMed ID: 7278927
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of CB-154 on acromegaly].
    Kato Y; Iwasaki Y; Chihara K; Imura H
    Horumon To Rinsho; 1977 Dec; 25(12):1332-6. PubMed ID: 598038
    [No Abstract]   [Full Text] [Related]  

  • 6. Bromocriptine reduces growth hormone in acromegaly.
    Bell PM; Atkinson AB; Hadden DR; Kennedy L; Leslie H; Merrett JD; Sheridan B
    Arch Intern Med; 1986 Jun; 146(6):1145-9. PubMed ID: 3718102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of CB-154 in acromegaly].
    Ishibashi M; Yamaji T
    Horumon To Rinsho; 1977 Dec; 25(12):1292-6. PubMed ID: 598022
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of CB-154 administration in acromegaly].
    Nakagawa K; Obara T
    Horumon To Rinsho; 1977 Dec; 25(12):1274-6. PubMed ID: 598017
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of acromegaly with decreased GH levels in the serum by the treatment of either metoclopramide or the combination with CB-154 (author's transl)].
    Naito T; Nakamura T; Suzuki H; Kasai K; Shiina H
    Horumon To Rinsho; 1980 Sep; 28(9):1026-30. PubMed ID: 7460352
    [No Abstract]   [Full Text] [Related]  

  • 10. The levels of pituitary-testicular axis hormones and SHBG in active acromegaly following bromocriptine treatment.
    Zwirska-Korczala K; Ostrowska Z; Zych F; Buntner B
    Endocr Regul; 1991 Dec; 25(4):211-6. PubMed ID: 1813034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of small doses of bromocriptine (Parlodel) on the serum level of growth hormone in acromegaly].
    Gáspár L; László F
    Orv Hetil; 1980 May; 121(20):1179-82. PubMed ID: 7413200
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of acromegaly using bromocriptine].
    Köbberling J; Schwinn G; Dirks H
    Dtsch Med Wochenschr; 1975 Jul; 100(29):1540-2. PubMed ID: 1149634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination therapy with bromocriptine and cyproheptadine in patients with acromegaly.
    Hanew K; Sugawara A; Shimizu Y; Sato S; Sasaki A; Tazawa S; Ishii K; Saitoh T; Saso S; Yoshinaga K
    Endocrinol Jpn; 1989 Jun; 36(3):429-38. PubMed ID: 2510991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine and acromegaly: therapeutic implications.
    Brooks AP; Stephen PJ; Nairn IM; Strong JA
    J R Soc Med; 1979 Aug; 72(8):562-4. PubMed ID: 552555
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison among the growth hormone-lowering effects in acromegaly of the somatostatin analog SMS 201-995, bromocriptine, and the combination of both drugs.
    Lamberts SW; Zweens M; Verschoor L; del Pozo E
    J Clin Endocrinol Metab; 1986 Jul; 63(1):16-9. PubMed ID: 2872225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests.
    Nortier JW; Croughs RJ; Thijssen JH; Schwarz F
    Clin Endocrinol (Oxf); 1984 May; 20(5):565-71. PubMed ID: 6744634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone and somatomedin levels in acromegalics treated with bromocriptine.
    Shalet SM; Price DA; Beardwell CG; Mindel A; MacFarlane IA
    Horm Res; 1980; 12(3):121-9. PubMed ID: 6768666
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of long-term treatment with bromocriptine on the growth hormone response to galanin in patients with acromegaly.
    Giustina A; Doga M; Bussi AR; Licini M; Schettino M
    Acta Endocrinol (Copenh); 1993 Feb; 128(2):131-5. PubMed ID: 7680832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of bromocriptine to alter the qualitative characteristics of human growth hormone in acromegaly.
    Hizuka N; Hendricks CM; Roth J; Gorden P
    Metabolism; 1984 Jun; 33(6):582-4. PubMed ID: 6727657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of the 24 hour integrated plasma concentration of growth hormone, in assessing the response of acromegalic patients to treatment.
    Daggett PR; Nabarro JD
    Clin Endocrinol (Oxf); 1977 Dec; 7(6):437-41. PubMed ID: 563781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.